Invention Grant
- Patent Title: Combination therapy using a LIV1-ADC and a chemotherapeutic
-
Application No.: US16085511Application Date: 2017-03-15
-
Publication No.: US11325980B2Publication Date: 2022-05-10
- Inventor: Django Sussman , Fu Li , Ana Kostic
- Applicant: SEATTLE GENETICS, INC.
- Applicant Address: US WA Bothell
- Assignee: SEATTLE GENETICS, INC.
- Current Assignee: SEATTLE GENETICS, INC.
- Current Assignee Address: US WA Bothell
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2017/022541 WO 20170315
- International Announcement: WO2017/161007 WO 20170921
- Main IPC: A61K31/337
- IPC: A61K31/337 ; A61K31/555 ; A61K31/704 ; C07K16/30 ; A61K39/395 ; A61K47/68 ; C07K16/28 ; A61K9/00 ; A61K39/00
Abstract:
The invention provides methods of treating a subject having or at risk of cancer by administering a LIV-1 antibody drug conjugate and a chemotherapeutic.
Public/Granted literature
- US20190085091A1 COMBINATION THERAPY USING A LIV1-ADC AND A CHEMOTHERAPEUTIC Public/Granted day:2019-03-21
Information query
